Literature DB >> 31342332

The HCV Treatment Cascade: Race Is a Factor to Consider.

Maya Balakrishnan1, Fasiha Kanwal2,3.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31342332      PMCID: PMC6816660          DOI: 10.1007/s11606-019-04962-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  14 in total

1.  Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.

Authors:  Nicole J Kim; Cameron J Locke; Helen Park; Catherine Magee; Peter Bacchetti; Mandana Khalili
Journal:  J Gen Intern Med       Date:  2018-09-20       Impact factor: 5.128

2.  Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.

Authors:  M Lin; J Kramer; D White; Y Cao; S Tavakoli-Tabasi; S Madu; D Smith; S M Asch; H B El-Serag; F Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2017-09-26       Impact factor: 8.171

3.  Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups.

Authors:  Barbara J Turner; Chen-Pin Wang; Trisha V Melhado; Raudel Bobadilla; Mamta K Jain; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12-06       Impact factor: 11.382

4.  Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease.

Authors:  Lisa I Backus; Pamela S Belperio; Troy A Shahoumian; Larry A Mole
Journal:  Hepatology       Date:  2018-05-15       Impact factor: 17.425

5.  Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.

Authors:  J Chhatwal; Q Chen; T Ayer; E D Bethea; F Kanwal; K V Kowdley; X Wang; M S Roberts; S C Gordon
Journal:  Aliment Pharmacol Ther       Date:  2018-01-29       Impact factor: 8.171

6.  Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.

Authors:  Monica L Kasting; Anna R Giuliano; Richard R Reich; Richard G Roetzheim; David R Nelson; Elizabeth Shenkman; Susan T Vadaparampil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-27       Impact factor: 4.254

7.  Disparities in hepatitis C virus infection screening among Baby Boomers in the United States.

Authors:  Mona Nili; Lucy Luo; Xue Feng; Jongwha Chang; Xi Tan
Journal:  Am J Infect Control       Date:  2018-07-14       Impact factor: 2.918

8.  Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.

Authors:  Hashem B El-Serag; Jennifer Kramer; Zhigang Duan; Fasiha Kanwal
Journal:  Am J Gastroenterol       Date:  2014-07-29       Impact factor: 10.864

9.  Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.

Authors:  Joanne E Brady; Claudia Vellozzi; Susan Hariri; Danielle L Kruger; David R Nerenz; Kimberly Ann Brown; Alex D Federman; Katherine Krauskopf; Natalie Kil; Omar I Massoud; Jenni M Wise; Toni Ann Seay; Bryce D Smith; Anthony K Yartel; David B Rein
Journal:  Am J Manag Care       Date:  2018-09       Impact factor: 2.229

Review 10.  The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Authors:  Baligh R Yehia; Asher J Schranz; Craig A Umscheid; Vincent Lo Re
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more
  3 in total

1.  Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C.

Authors:  Jennifer Conti; Eileen Dryden; B Graeme Fincke; Shawn Dunlap; D Keith McInnes
Journal:  J Gen Intern Med       Date:  2022-07-25       Impact factor: 6.473

Review 2.  Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients.

Authors:  Nouhoum Bouare; Mamadou Keita; Jean Delwaide
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

3.  Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States.

Authors:  Martin Hoenigl; Daniela Abramovitz; Ricardo E Flores Ortega; Natasha K Martin; Nancy Reau
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.